BioCardia, Inc. (BCDA)
NASDAQ: BCDA · IEX Real-Time Price · USD
2.850
-0.030 (-1.04%)
Jul 22, 2024, 9:58 AM EDT - Market open
BioCardia Employees
As of December 31, 2023, BioCardia had 20 total employees, including 16 full-time and 4 part-time employees. The number of employees decreased by 16 or -44.44% compared to the previous year.
Employees
20
Change (1Y)
-16
Growth (1Y)
-44.44%
Revenue / Employee
$23,400
Profits / Employee
-$516,850
Market Cap
5.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Leafly Holdings | 131 |
Biofrontera | 85 |
ENDRA Life Sciences | 21 |
FSD Pharma | 17 |
TransCode Therapeutics | 10 |
Synaptogenix | 5 |
Lixte Biotechnology Holdings | 4 |
BCDA News
- 5 days ago - BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application - GlobeNewsWire
- 6 weeks ago - BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach - GlobeNewsWire
- 2 months ago - BioCardia Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - BioCardia Reports First Quarter 2024 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024 - GlobeNewsWire
- 2 months ago - BioCardia's CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes - GlobeNewsWire
- 3 months ago - BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort - GlobeNewsWire
- 4 months ago - BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results - GlobeNewsWire